Mendus AB (OSTO:IMMU) Cash Flow from Others : kr1.27 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mendus AB Cash Flow from Others?

Mendus AB's cash flow from others for the three months ended in Dec. 2024 was kr4.21 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was kr1.27 Mil.

Mendus AB Cash Flow from Others Historical Data

The historical data trend for Mendus AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Cash Flow from Others Chart

Mendus AB Annual Data

Trend

Jun15

Jun16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Others

Get a 7-Day Free Trial

4.66

-16.16

0.19

-4.75

2.63

Mendus AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow from Others	Get a 7-Day Free Trial															21.68	-2.61	-0.24	-0.09	4.21

Mendus AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.27 Mil.

Mendus AB Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Mendus AB's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Mendus AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

1YG0:Germany

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, 11153

Website

https://www.mendus.com

Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.